136 related articles for article (PubMed ID: 28294054)
21. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
Patel MM; Patel BM
CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766
[TBL] [Abstract][Full Text] [Related]
22. PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats.
Kaminskas LM; Kota J; McLeod VM; Kelly BD; Karellas P; Porter CJ
J Control Release; 2009 Dec; 140(2):108-16. PubMed ID: 19686787
[TBL] [Abstract][Full Text] [Related]
23. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
24. Chemical Structure and Surface Modification of Dendritic Nanomaterials Tailored for Therapeutic and Diagnostic Applications.
Myung JH; Hsu HJ; Bugno J; Tam KA; Hong S
Curr Top Med Chem; 2017; 17(13):1542-1554. PubMed ID: 28017148
[TBL] [Abstract][Full Text] [Related]
25. Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats.
Boyd BJ; Kaminskas LM; Karellas P; Krippner G; Lessene R; Porter CJ
Mol Pharm; 2006; 3(5):614-27. PubMed ID: 17009860
[TBL] [Abstract][Full Text] [Related]
26. Generation-6 hydroxyl PAMAM dendrimers improve CNS penetration from intravenous administration in a large animal brain injury model.
Zhang F; Trent Magruder J; Lin YA; Crawford TC; Grimm JC; Sciortino CM; Wilson MA; Blue ME; Kannan S; Johnston MV; Baumgartner WA; Kannan RM
J Control Release; 2017 Mar; 249():173-182. PubMed ID: 28137632
[TBL] [Abstract][Full Text] [Related]
27. Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer.
Kesharwani P; Tekade RK; Jain NK
Biomaterials; 2014 Jul; 35(21):5539-48. PubMed ID: 24731713
[TBL] [Abstract][Full Text] [Related]
28. Dendrimers: Patents for Alzheimer's Disease.
Maheshwari S; Singh A
Recent Pat Nanotechnol; 2023 Oct; ():. PubMed ID: 37904560
[TBL] [Abstract][Full Text] [Related]
29. Effects of PEGylation and acetylation of PAMAM dendrimers on DNA binding, cytotoxicity and in vitro transfection efficiency.
Fant K; Esbjörner EK; Jenkins A; Grossel MC; Lincoln P; Nordén B
Mol Pharm; 2010 Oct; 7(5):1734-46. PubMed ID: 20695423
[TBL] [Abstract][Full Text] [Related]
30. Dendrimer nanocarriers for transport modulation across models of the pulmonary epithelium.
Bharatwaj B; Mohammad AK; Dimovski R; Cassio FL; Bazito RC; Conti D; Fu Q; Reineke J; da Rocha SR
Mol Pharm; 2015 Mar; 12(3):826-38. PubMed ID: 25455560
[TBL] [Abstract][Full Text] [Related]
31. Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies.
Na M; Yiyun C; Tongwen X; Yang D; Xiaomin W; Zhenwei L; Zhichao C; Guanyi H; Yunyu S; Longping W
Eur J Med Chem; 2006 May; 41(5):670-4. PubMed ID: 16527374
[TBL] [Abstract][Full Text] [Related]
32. Effect of the Conjugation Density of Triphenylphosphonium Cation on the Mitochondrial Targeting of Poly(amidoamine) Dendrimers.
Bielski ER; Zhong Q; Brown M; da Rocha SR
Mol Pharm; 2015 Aug; 12(8):3043-53. PubMed ID: 26158804
[TBL] [Abstract][Full Text] [Related]
33. Development of PEGylated carboxylic acid-modified polyamidoamine dendrimers as bone-targeting carriers for the treatment of bone diseases.
Yamashita S; Katsumi H; Hibino N; Isobe Y; Yagi Y; Kusamori K; Sakane T; Yamamoto A
J Control Release; 2017 Sep; 262():10-17. PubMed ID: 28710004
[TBL] [Abstract][Full Text] [Related]
34. Carboxymethyl chitosan-poly(amidoamine) dendrimer core-shell nanoparticles for intracellular lysozyme delivery.
Zhang X; Zhao J; Wen Y; Zhu C; Yang J; Yao F
Carbohydr Polym; 2013 Nov; 98(2):1326-34. PubMed ID: 24053810
[TBL] [Abstract][Full Text] [Related]
35. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
[TBL] [Abstract][Full Text] [Related]
36. Ligand anchored poly(propyleneimine) dendrimers for brain targeting: Comparative in vitro and in vivo assessment.
Patel HK; Gajbhiye V; Kesharwani P; Jain NK
J Colloid Interface Sci; 2016 Nov; 482():142-150. PubMed ID: 27501037
[TBL] [Abstract][Full Text] [Related]
37. Gene delivery efficiency and cytotoxicity of heterocyclic amine-modified PAMAM and PPI dendrimers.
Hashemi M; Tabatabai SM; Parhiz H; Milanizadeh S; Amel Farzad S; Abnous K; Ramezani M
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():791-800. PubMed ID: 26838910
[TBL] [Abstract][Full Text] [Related]
38. Surface functionality affects the biodistribution and microglia-targeting of intra-amniotically delivered dendrimers.
Zhang F; Nance E; Zhang Z; Jasty V; Kambhampati SP; Mishra MK; Burd I; Romero R; Kannan S; Kannan RM
J Control Release; 2016 Sep; 237():61-70. PubMed ID: 27378700
[TBL] [Abstract][Full Text] [Related]
39. Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier.
Yan C; Gu J; Hou D; Jing H; Wang J; Guo Y; Katsumi H; Sakane T; Yamamoto A
Drug Dev Ind Pharm; 2015 Apr; 41(4):617-22. PubMed ID: 24564798
[TBL] [Abstract][Full Text] [Related]
40. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
